Immune Control Despite Protracted Lymphopenia After Chemoradiation in an Elite Controller
Related Experiment Video
Updated: Mar 24, 2026
12:16
A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
Published on: October 16, 2018
15.7K
Kim A Reiss1, Dvone C Jackson2, Anna Piotrowski2
1Department of Medicine, Hematology-Oncology Division , University of Pennsylvania School of Medicine , Philadelphia.
Open Forum Infectious Diseases
|March 8, 2016
Abstract:
Elite controllers are human immunodeficiency virus-1-positive individuals capable of sustaining undetectable viral loads without treatment. We present the case of an elite controller diagnosed with extensive stage small cell lung cancer who maintained a viral load of <20 copies/mL despite the development of severe treatment-related lymphopenia.
